Abstract
In order to identify a transcription component of programmed cell death (PCD), this review compiles and cross-compares genome-scale gene expression analyses of several models of apoptosis. Large-scale transcription profiling studies to date have utilized diverse technologies such as cDNA arrays and serial analysis of gene expression (SAGE). Despite the varying technology platforms, commonly regulated genes were identified and fell into three major categories those related to the regulation of cell cycle, inflammatory responses, and oxidative stress. The observation that common markers were regulated across different models of apoptosis demonstrates the utility of genome-scale gene expression analysis for cell death pathway mining.
Keywords: Apoptosis, Arrays, Programmed Cell Death, serial analysis of gene expression sage, Validation
Current Genomics
Title: Apoptosis and Arrays: Identifying a Transcription Component of Programmed Cell Death
Volume: 3 Issue: 1
Author(s): Lillian W. Chiang
Affiliation:
Keywords: Apoptosis, Arrays, Programmed Cell Death, serial analysis of gene expression sage, Validation
Abstract: In order to identify a transcription component of programmed cell death (PCD), this review compiles and cross-compares genome-scale gene expression analyses of several models of apoptosis. Large-scale transcription profiling studies to date have utilized diverse technologies such as cDNA arrays and serial analysis of gene expression (SAGE). Despite the varying technology platforms, commonly regulated genes were identified and fell into three major categories those related to the regulation of cell cycle, inflammatory responses, and oxidative stress. The observation that common markers were regulated across different models of apoptosis demonstrates the utility of genome-scale gene expression analysis for cell death pathway mining.
Export Options
About this article
Cite this article as:
Chiang W. Lillian, Apoptosis and Arrays: Identifying a Transcription Component of Programmed Cell Death, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350624
DOI https://dx.doi.org/10.2174/1389202023350624 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Astatine Radiopharmaceuticals: Prospects and Problems
Current Radiopharmaceuticals Production of Retroviral Vectors: Review
Current Gene Therapy Gene Therapy to Overcome Drug Resistance in Cancer: Targeting Key Regulators of the Apoptotic Pathway
Current Gene Therapy Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria
Current Topics in Medicinal Chemistry Clinical Outcomes of the Transplantation of Stem Cells from Various Human Tissue Sources in the Management of Liver Cirrhosis: A Systematic Review and Meta-Analysis
Current Stem Cell Research & Therapy Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy α-Secretase in Alzheimers Disease and Beyond: Mechanistic, Regulation and Function in the Shedding of Membrane Proteins
Current Alzheimer Research Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials Cancer Gene Therapy Utilizing Interleukin-13 Receptor α2 Chain
Current Gene Therapy Molecular Targeting of Lymphatics for Therapy
Current Pharmaceutical Design Transport Mechanism-Based Drug Molecular Design: Novel Camptothecin Analogues to Circumvent ABCG2-associated Drug Resistance of Human Tumor Cells
Current Pharmaceutical Design Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases
Current Cancer Drug Targets Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery Thioguanine, Mercaptopurine: Their Analogs and Nucleosides as Antimetabolites
Current Pharmaceutical Design